Author

K. Kudo

Observed name: Kennichiro Kudo

Institution: Osaka Minami Medical Center

Observed institutions: Osaka Minami Medical Center, Iwakuni Medical Center

OpenAlex ID: A5039720474

Vogt-Koyanagi-Harada Syndrome Induced by Pembrolizumab in a Patient with Non–Small Cell Lung Cancer

2018 · Tomoki Tamura, Etsuko Akimoto, et al. · Journal of Thoracic Oncology · 29

P1.07-010 Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with Nivolumab

2017 · J. Tanizaki, K. Haratani, et al. · Journal of Thoracic Oncology · 2

Phase II study of erlotinib for acquired resistance to gefitinib in patients with advanced non-small cell lung cancer.

2010 · A. Horiike, N. Yamamoto, et al. · Journal of Clinical Oncology · 2

A randomized trial of sodium alginate prevention of radiation-induced esophagitis in patients with locally advanced NSCLC receiving concurrent chemoradiotherapy: OLCSG1401

2019 · T. Yokoyama, K. Ninomiya, et al. · Annals of Oncology · 1

1873P Comparison of the efficacy of ipilimumab plus nivolumab with or without chemotherapy based on baseline tumor size: A sub-analysis of TOPGAN2023-01

2025 · H. Tanaka, T. Makiguchi, et al. · Annals of Oncology

P1.03-038 A Phase I Trial of Afatinib and Bevacizumab in Untreated Patients with Advanced NSCLC Harboring EGFR-Mutations: OLCSG1404

2017 · S. Kuyama, K. Kudo, et al. · Journal of Thoracic Oncology

Impact of immune checkpoint inhibitors on subsequent chemotherapy

2017 · H. Watanabe, T. Kubo, et al. · Annals of Oncology

Works count: 7

Citation count: 34

H-index: 2

I10-index: 1